Company Filing History:
2 out of 961 
2 out of 88 
Years Active: 2023-2025
Title: Scott Peterson: Innovator in Cancer Treatment
Introduction
Scott Peterson is a notable inventor based in La Jolla, California. He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of 2 patents, Peterson's work focuses on the relationship between gut microbiota and cancer.
Latest Patents
Peterson's latest patents revolve around the role of the ubiquitin ligase, RNF5, in regulating gut microbiota composition and its influence on immune checkpoint responses to tumors. His research indicates that RNF5 deficient animals show significant inhibition of tumor development alongside an altered gut microbiota composition. The patents disclose methods for treating cancer by administering selected bacterial species and/or prebiotics that promote the growth of these bacterial species. Additionally, they explore the combination of these treatments with anti-cancer agents to enhance therapeutic efficacy.
Career Highlights
Throughout his career, Scott Peterson has worked with esteemed organizations such as the Technion Research & Development Foundation Limited and the Sanford Burnham Prebys Medical Discovery Institute. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of Peterson's notable coworkers include Yan Li and Roberto Tinoco. Their collaborative efforts have further enriched the research landscape in which Peterson operates.
Conclusion
Scott Peterson's innovative work in cancer treatment through the study of gut microbiota exemplifies the intersection of microbiology and oncology. His patents and research continue to pave the way for new therapeutic strategies in combating cancer.